The National Center for Advancing Translational Sciences (NCATS) is announcing an open opportunity to submit proposals to collaborate with the Therapeutics for Rare and Neglected Diseases (TRND) program.
The TRND program performs preclinical and early clinical development of new drugs for rare and neglected tropical diseases, and develops new technologies and paradigms to improve the efficiency of therapeutic development for these disorders. TRND seeks collaborative partnerships with academic laboratories, not-for-profit organizations, and for-profit companies. This is not a grant program, and no extramural funds will be provided.
Please visit the TRND information on the NCATS website and the related NIH Guide Notice for complete details regarding program scope, eligibility, and application process. Letters of Intent are due no later than September 16, and full proposals must be submitted by September 30.
NIH Funding Acknowledgment:Important Reminder – Please acknowledge the NIH when publishing papers, patents, projects, and presentations resulting from the use of CTSI resources by including the NIH Funding Acknowledgement.
